Iovance Biotherapeutics develops T-cell-based immunotherapy products for the treatment of cancer. Founded by Manish Singh in 2007, Iovance Biotherapeutics is backed by investors that include Broadfin Capital, Frazier Healthcare Partners, OrbiMed, and Quogue Capital and is headquartered in New York.
FOUNDED:
2007
INDUSTRY:
Biotechnology, Health Care, Medical
FOUNDERS:
Manish Singh
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
